NASDAQ : NUTX
Nutex Health Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 200.15 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.37B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.29B |
| Enterprise Value | 1.43B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.85M |
| Shares Outstanding | 6.85M |
| Shares Change (YoY) | +14.84% |
| Shares Change (QoQ) | -2.20% |
| Owned by Insiders (%) | 32.87% |
| Owned by Institutions (%) | 36.39% |
| Float | 4.15M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 7.45 |
| Forward PE | 7.44 |
| PS Ratio | 1.62 |
| Forward PS | 1.50 |
| PB Ratio | 3.47 |
| P/TBV Ratio | 3.81 |
| P/FCF Ratio | 5.04 |
| P/OCF Ratio | 4.90 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 8.41 |
| EV / Sales | 1.79 |
| EV / EBITDA | 3.01 |
| EV / EBIT | 3.14 |
| EV / FCF | 5.56 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.00 |
| Quick Ratio | 4.79 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 1.28 |
| Interest Coverage | 24.33 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 64.56% |
| Return on Assets (ROA) | 33.32% |
| Return on Invested Capital (ROIC) | 61.92% |
| Return on Capital Employed (ROCE) | 56.79% |
| Weighted Average Cost of Capital (WACC) | 13.09% |
| Revenue Per Employee | $816,509 |
| Profits Per Employee | $173,499 |
| Employee Count | 1,037 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 118.85 |
Taxes
| Measure | Value |
|---|
| Income Tax | 70.99M |
| Effective Tax Rate | 20.67% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.00 |
| 52-Week Price Change | +57.84% |
| 50-Day Moving Average | 203.41 |
| 200-Day Moving Average | 150.59 |
| Relative Strength Index (RSI) | 42.77 |
| Average Volume (20 Days) | 127,800 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.24M |
| Short Previous Month | 1.25M |
| Short % of Shares Out | 18.07% |
| Short % of Float | 29.85% |
| Short Ratio (days to cover) | 7.83 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 846.72M |
| Gross Profit | 461.53M |
| Operating Income | 481.27M |
| Pretax Income | 343.48M |
| Net Income | 179.92M |
| EBITDA | 502.27M |
| EBIT | 481.27M |
| Earnings Per Share (EPS) | $25.24 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 205.21M |
| Total Debt | 347.34M |
| Net Cash | -142.13M |
| Net Cash Per Share | -$20.75 |
| Equity (Book Value) | 507.31M |
| Book Value Per Share | 57.62 |
| Working Capital | 468.43M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 279.62M |
| Capital Expenditures | -7.77M |
| Depreciation & Amortization | 21.00M |
| Net Borrowing | -22.63M |
| Free Cash Flow | 271.85M |
| FCF Per Share | $39.70 |
Margins
| Measure | Value |
|---|
| Gross Margin | 54.51% |
| Operating Margin | 56.84% |
| Pretax Margin | 40.57% |
| Profit Margin | 21.25% |
| EBITDA Margin | 59.32% |
| EBIT Margin | 56.84% |
| FCF Margin | 32.11% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -14.84% |
| Shareholder Yield | -14.84% |
| Earnings Yield | 13.42% |
| FCF Yield | 19.83% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $296.17 |
| Price Target Difference | 57.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 5.03% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.88 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |